VALENCE LIFE SCIENCES
Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing. Our team has insight on what drives success from assessing management and clinical development plans for over 25 years.
VALENCE LIFE SCIENCES
Industry:
Angel Investment Life Science Venture Capital
Founded:
2012-01-01
Status:
Active
Contact:
(212) 521-4379
Technology used in webpage:
Amazon
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
CSC Upshot
CSC Upshot is an early stage venture fund focusing on providing seed capital to technology companies at scale.
JLS Fund
JLS Fund is a venture capital firm that invests in the psychedelics and technology intersection.
LifeSci Venture Partners
LifeSci Venture Partners is an early-stage investment firm that invests in early-stage life sciences and healthcare companies.
Nimble Partners
Nimble Partners is an investment management firm providing strategic advice and investments in early-stage companies.
Quaker BioVentures
Quaker BioVentures is a venture capital firm investing in life science companies. The firm leads investments across the spectrum of the
Ten Eleven Ventures
Ten Eleven Ventures is the original cybersecurity-focused, global, stage agnostic investment firm.
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-03-11 | CalciMedica | Valence Life Sciences investment in Series D - CalciMedica | 21 M USD |
| 2020-05-22 | CalciMedica | Valence Life Sciences investment in Series C - CalciMedica | 15 M USD |
| 2020-02-05 | JenaValve Technology | Valence Life Sciences investment in Venture Round - JenaValve Technology | 50 M USD |
| 2015-02-13 | Invuity | Valence Life Sciences investment in Private Equity Round - Invuity | 22.9 M USD |
| 2014-03-04 | Invuity | Valence Life Sciences investment in Series E - Invuity | 36 M USD |
| 2013-04-30 | Celator Pharmaceuticals | Valence Life Sciences investment in Private Equity Round - Celator Pharmaceuticals | 39.3 M USD |
| 2012-06-14 | Invuity | Valence Life Sciences investment in Series D - Invuity | 25 M USD |
| 2012-01-09 | Invuity | Valence Life Sciences investment in Venture Round - Invuity | 2 M USD |
More informations about "Valence Life Sciences"
Valence Life Sciences - Crunchbase Investor Profile & Investments
Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing. Our team has insight on what drives success from assessing …See details»
Valence Life Sciences - Investments, Portfolio & Company Exits
Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»
Valence Life Sciences
Learn more about our Founding Managing Directors: A. Rachel Leheny, PhD, and Eric W. Roberts. A. Rachel Leheny, PhD, and Eric W. Roberts.See details»
Valence Life Sciences
A private company rapidly advancing transformative therapies for patients with life threatening viral diseases. calcimedica A public company developing novel drugs for inflammatory and …See details»
Valence Life Sciences - Funding, Financials, Valuation & Investors
Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing. Search Crunchbase. Start Free Trial . Chrome Extension. ... Valence …See details»
Valence Life Sciences - LinkedIn
The only life sciences venture firm with a proven track record of success in late-stage investing. | Valence Life Sciences is a biotech venture capital fund based out of 500 Park Avenue, New …See details»
Valence Life Sciences investment portfolio | PitchBook
Jun 15, 2015 Valence Life Sciences's latest investment was on 11-Mar-2021 in CalciMedica, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. …See details»
Valence Life Sciences - teaserclub.com
Valence Life Sciences is a New York-based venture capital firm established in 2012, specializing in late-stage investments within the life sciences sector. The firm primarily focuses on …See details»
Valence Life Sciences - Massinvestor Venture Capital and Private …
Valence Life Sciences is a leading life sciences investment firm focused on late-stage private and micro-cap public drug development companies. Valence Advantage Life Sciences Fund II was …See details»
Valence Life Sciences - CB Insights
The round was led by Valence Life Sciences, with participation from new investors Bering Capital, Mesa Verde Venture Partners and existing investor Sanderling Ventures. The company …See details»
Valence Life Sciences – Investors Database – Unicorn Nest
The higher amount of exits for fund were in 2015. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies. The important …See details»
Valence Life Sciences - Overview, News & Similar companies
Who is Valence Life Sciences. Valence Life Sciences is a New York and San Diego-based life sciences venture capital firm founded to focus on clinical development stage private a nd …See details»
Valence Life Sciences - Crunchbase
Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»
Valence Life Sciences - Private Equity International
Valence Life Sciences. News, insights, analysis and data. Valence Life Sciences overview. Founded in 2012, Valence Life Sciences is a New York-based firm focused on late-stage …See details»
Valence Life Sciences
In 2012, Dr. Leheny co-founded Valence Life Sciences. Prior to Valence Life Sciences, Dr. Leheny managed Caxton Advantage which she co-founded in 2004. ... Anthera …See details»
Valence Life Sciences Overview | SignalHire Company Profile
Valence Life Sciences is a investment company company that has been in the industry for 10 years. The company currently specializes in the Venture Capital & Private Equity area. ...See details»
Caxton Advantage Venture Partners Announces Formation of …
Feb 23, 2012 Valence Life Sciences is a New York - and San Diego-based life sciences venture capital firm founded by Dr. Rachel Leheny and Eric Roberts to focus on clinical development …See details»
Life Sciences Ontario Celebrates Excellence and Innovation in Life ...
6 days ago Life Sciences Ontario (LSO) is a member-funded, not-for-profit organization with a legacy of more than 35 years advancing the success of Ontario’s life sciences sector.See details»
Valence Life Sciences
In 2012, Mr. Roberts co-founded investment firm, Valence Life Sciences. Prior to Valence Life Sciences, Mr. Roberts managed the Caxton Advantage Life Sciences Fund which he co …See details»
Assessing well-being in clinical research and treatment
2 days ago This Perspective discusses methodological and theoretical challenges for measuring well-being in clinical research and the importance of including well-being measures in clinical …See details»